These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33170059)

  • 1.
    Mehri R; Alatrash A; Ogrodnik N; Matida EA; Fiorenza F
    J Aerosol Med Pulm Drug Deliv; 2021 Aug; 34(4):242-250. PubMed ID: 33170059
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro validation of a Respimat® adapter for delivery of inhaled bronchodilators during mechanical ventilation.
    Dellweg D; Wachtel H; Höhn E; Pieper MP; Barchfeld T; Köhler D; Glaab T
    J Aerosol Med Pulm Drug Deliv; 2011 Dec; 24(6):285-92. PubMed ID: 21870959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pressurized Metered-Dose Inhalers Versus Nebulizers in the Treatment of Mechanically Ventilated Subjects With Artificial Airways: An In Vitro Study.
    Ari A; Harwood RJ; Sheard MM; Fink JB
    Respir Care; 2015 Nov; 60(11):1570-4. PubMed ID: 26152470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro Evaluation of Aerosol Performance and Delivery Efficiency During Mechanical Ventilation Between Soft Mist Inhaler and Pressurized Metered-Dose Inhaler.
    Ke WR; Wang WJ; Lin TH; Wu CL; Huang SH; Wu HD; Chen CC
    Respir Care; 2020 Jul; 65(7):1001-1010. PubMed ID: 32071134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oronasal and Tracheostomy Delivery of Soft Mist and Pressurized Metered-Dose Inhalers With Valved Holding Chamber.
    Berlinski A; Cooper B
    Respir Care; 2016 Jul; 61(7):913-9. PubMed ID: 27006348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental Study of Spiriva Respimat Soft Mist Inhaler Spray Characterization: Size Distributions and Velocity.
    Alatrash A; Mehri R; Ogrodnik N; Matida E; Fiorenza F
    J Aerosol Med Pulm Drug Deliv; 2019 Oct; 32(5):293-302. PubMed ID: 31259646
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of patients' real-world post-dispensing use and storage environments of tiotropium bromide Respimat® soft mist inhaler on its in vitro dose delivery and lung deposition.
    Ammari WG; Khalil Mohammad M; Tayyem RF
    Pulm Pharmacol Ther; 2019 Oct; 58():101829. PubMed ID: 31352077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher lung deposition with Respimat Soft Mist inhaler than HFA-MDI in COPD patients with poor technique.
    Brand P; Hederer B; Austen G; Dewberry H; Meyer T
    Int J Chron Obstruct Pulmon Dis; 2008; 3(4):763-70. PubMed ID: 19281091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Respimat
    Iwanaga T; Tohda Y; Nakamura S; Suga Y
    Clin Drug Investig; 2019 Nov; 39(11):1021-1030. PubMed ID: 31377981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers.
    Hochrainer D; Hölz H; Kreher C; Scaffidi L; Spallek M; Wachtel H
    J Aerosol Med; 2005; 18(3):273-82. PubMed ID: 16181002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro performance of spacers for aerosol delivery during adult mechanical ventilation.
    Boukhettala N; Porée T; Diot P; Vecellio L
    J Aerosol Med Pulm Drug Deliv; 2015 Apr; 28(2):130-6. PubMed ID: 25050644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Different Closed Suction Catheter Designs and pMDI Adapters on Aerosol Delivery in Simulated Adult Mechanical Ventilation With and Without Exhaled Humidity.
    Williams JP; Ari A; Shanmugam R; Fink JB
    Respir Care; 2018 Sep; 63(9):1154-1161. PubMed ID: 29844214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of comparative studies of tiotropium Respimat® and tiotropium HandiHaler® in patients with chronic obstructive pulmonary disease: does inhaler choice matter?
    Dahl R; Kaplan A
    BMC Pulm Med; 2016 Oct; 16(1):135. PubMed ID: 27724909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced Environmental Impact of the Reusable Respimat
    Hänsel M; Bambach T; Wachtel H
    Adv Ther; 2019 Sep; 36(9):2487-2492. PubMed ID: 31317391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the development of Respimat Soft Mist Inhaler.
    Dalby R; Spallek M; Voshaar T
    Int J Pharm; 2004 Sep; 283(1-2):1-9. PubMed ID: 15363496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of ipratropium bromide/fenoterol hydrobromide (Berodual) delivered via Respimat Soft Mist Inhaler in patients with asthma and chronic obstructive pulmonary disease.
    Kässner F; Hodder R; Bateman ED
    Drugs; 2004; 64(15):1671-82. PubMed ID: 15257628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Heat Moisture Exchanger on Aerosol Drug Delivery and Airway Resistance in Simulated Ventilator-Dependent Adults Using Jet and Mesh Nebulizers.
    Ari A; Dang T; Al Enazi FH; Alqahtani MM; Alkhathami A; Qoutah R; Almamary AS; Fink JB
    J Aerosol Med Pulm Drug Deliv; 2018 Feb; 31(1):42-48. PubMed ID: 28829202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhalation therapy with metered-dose inhalers and dry powder inhalers in mechanically ventilated patients.
    Dhand R
    Respir Care; 2005 Oct; 50(10):1331-4; discussion 1344-5. PubMed ID: 16185369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of eco-friendly inhalers: focus on combination ipratropium bromide and albuterol in chronic obstructive pulmonary disease.
    Panos RJ
    Int J Chron Obstruct Pulmon Dis; 2013; 8():221-30. PubMed ID: 23658481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.
    Brocklebank D; Ram F; Wright J; Barry P; Cates C; Davies L; Douglas G; Muers M; Smith D; White J
    Health Technol Assess; 2001; 5(26):1-149. PubMed ID: 11701099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.